Birchview Capital, LP Diversified Active

CIK: 0001618205 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 12, 2021

Total Value ($000): $146,958 (100.0% shares, 0.0% debt)

Holdings (64)

BMY BRISTOL-MYERS SQUIBB CO 32.1%
Value ($000) $47,106 Shares 796,106 Est. Cost $44.70 Unrealized +22.7%
ACCELERATE DIAGNOSTICS INC 8.9%
Value ($000) $13,096 Shares 2,252,388 Est. Cost $19.28 Unrealized
BIODESIX INC 6.2%
Value ($000) $9,083 Shares 1,104,953 Est. Cost $20.16 Unrealized
QUIDEL CORP 5.7%
Value ($000) $8,424 Shares 59,684 Est. Cost $67.34 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 5.2%
Value ($000) $7,692 Shares 80,200 Est. Cost $70.20 Unrealized +34.6%
FHTX FOGHORN THERAPEUTICS INC 3.0%
Value ($000) $4,376 Shares 314,143 Est. Cost $19.16 Unrealized -42.2%
BIIB BIOGEN INC 2.4%
Value ($000) $3,566 Shares 12,600 Est. Cost $288.92 Unrealized +13.4%
ALBIREO PHARMA INC 2.4%
Value ($000) $3,526 Shares 113,000 Est. Cost $34.29 Unrealized
UTHR UNITED THERAPEUTICS CORP 2.3%
Value ($000) $3,322 Shares 18,000 Est. Cost $93.09 Unrealized +111.6%
ACAD ACADIA PHARMACEUTICALS INC 2.3%
Value ($000) $3,312 Shares 199,400 Est. Cost $39.29 Unrealized -50.9%
PRTA PROTHENA CORP PLC 2.0%
Value ($000) $2,867 Shares 40,247 Est. Cost $38.88 Unrealized +59.7%
MASI MASIMO CORP 1.5%
Value ($000) $2,166 Shares 8,000 Est. Cost $24.68 Unrealized +998.7%
ACCELERON PHARMA INC 1.3%
Value ($000) $1,837 Shares 10,672 Est. Cost $36.87 Unrealized
CONTINENTAL RESOURCES INC 1.2%
Value ($000) $1,781 Shares 38,600 Est. Cost $17.54 Unrealized
HROW HARROW HEALTH INC 1.1%
Value ($000) $1,636 Shares 180,000 Est. Cost $6.05 Unrealized +49.7%
BLUEBIRD BIO INC 1.1%
Value ($000) $1,605 Shares 84,000 Est. Cost $50.76 Unrealized
ALKS ALKERMES PLC 1.0%
Value ($000) $1,542 Shares 50,000 Est. Cost $21.00 Unrealized +34.5%
AMARIN CORP PLC 1.0%
Value ($000) $1,530 Shares 300,000 Est. Cost $7.50 Unrealized
KARYOPHARM THERAPEUTICS INC 1.0%
Value ($000) $1,432 Shares 246,000 Est. Cost $15.28 Unrealized
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD 0.9%
Value ($000) $1,389 Shares 10,000 Est. Cost $54.40 Unrealized
VNDA VANDA PHARMACEUTICALS INC 0.9%
Value ($000) $1,371 Shares 80,000 Est. Cost $14.87 Unrealized +17.8%
EQUITRANS MIDSTREAM CORPORATIO 0.9%
Value ($000) $1,349 Shares 133,050 Est. Cost $8.31 Unrealized
ARENA PHARMACEUTICALS INC 0.9%
Value ($000) $1,310 Shares 22,000 Est. Cost $41.96 Unrealized
NEKTAR THERAPEUTICS 0.9%
Value ($000) $1,293 Shares 72,000 Est. Cost $20.00 Unrealized
ARVN ARVINAS INC 0.8%
Value ($000) $1,233 Shares 15,000 Est. Cost $16.46 Unrealized +436.9%
OVV OVINTIV INC 0.8%
Value ($000) $1,124 Shares 34,200 Est. Cost $6.97 Unrealized +296.1%
IMMUNOGEN INC 0.7%
Value ($000) $1,077 Shares 190,000 Est. Cost $2.74 Unrealized
CGEM CULLINAN ONCOLOGY INC 0.7%
Value ($000) $1,018 Shares 45,114 Est. Cost $40.60 Unrealized -34.1%
CORT CORCEPT THERAPEUTICS INC 0.7%
Value ($000) $984 Shares 50,000 Est. Cost $6.85 Unrealized +205.4%
CYTK CYTOKINETICS INC 0.6%
Value ($000) $894 Shares 25,000 Est. Cost $27.06 Unrealized +8.8%
PGNY PROGYNY INC 0.6%
Value ($000) $840 Shares 15,000 Est. Cost $23.98 Unrealized +130.4%
SOLENO THERAPEUTICS INC 0.6%
Value ($000) $811 Shares 876,899 Est. Cost $2.18 Unrealized
CONTRAFECT CORP 0.6%
Value ($000) $810 Shares 200,000 Est. Cost $0.81 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 0.5%
Value ($000) $698 Shares 40,000 Est. Cost $18.69 Unrealized +8.5%
PTGX PROTAGONIST THERAPEUTICS INC 0.5%
Value ($000) $673 Shares 38,000 Est. Cost $38.07 Unrealized +12.0%
PIONEER NATURAL RESOURCES CO 0.4%
Value ($000) $633 Shares 3,800 Est. Cost $145.33 Unrealized
INARI MEDICAL INC 0.4%
Value ($000) $568 Shares 7,000 Est. Cost $48.40 Unrealized
G1 THERAPEUTICS INC 0.4%
Value ($000) $537 Shares 40,000 Est. Cost $33.05 Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 0.4%
Value ($000) $533 Shares 8,000 Est. Cost $53.56 Unrealized +7.7%
ANGION BIOMEDICA CORP 0.4%
Value ($000) $531 Shares 54,392 Est. Cost $18.06 Unrealized
TURNING POINT THERAPEUTICS INC 0.4%
Value ($000) $531 Shares 8,000 Est. Cost $78.00 Unrealized
GOSS GOSSAMER BIO INC 0.3%
Value ($000) $503 Shares 40,000 Est. Cost $9.21 Unrealized 0.0%
TGTX TG THERAPEUTICS INC 0.3%
Value ($000) $499 Shares 15,000 Est. Cost $13.75 Unrealized +125.0%
CHEMOCENTRYX INC 0.3%
Value ($000) $428 Shares 25,000 Est. Cost $39.66 Unrealized
PROGENITY INC 0.3%
Value ($000) $410 Shares 270,000 Est. Cost $5.27 Unrealized
XNCR XENCOR INC 0.3%
Value ($000) $402 Shares 12,300 Est. Cost $15.78 Unrealized +108.1%
APLS APELLIS PHARMACEUTICALS INC 0.3%
Value ($000) $396 Shares 12,000 Est. Cost $37.18 Unrealized +51.1%
STOK STOKE THERAPEUTICS INC 0.3%
Value ($000) $382 Shares 15,000 Est. Cost $24.71 Unrealized +12.8%
FOLD AMICUS THERAPEUTICS INC 0.2%
Value ($000) $363 Shares 38,000 Est. Cost $14.56 Unrealized -29.8%
ELUT AZIYO BIOLOGICS INC 0.2%
Value ($000) $348 Shares 50,000 Est. Cost $10.18 Unrealized -19.9%
KINIKSA PHARMACEUTICALS LTD 0.2%
Value ($000) $342 Shares 30,000 Est. Cost $13.10 Unrealized
ASPIRA WOMENS HEALTH INC 0.2%
Value ($000) $335 Shares 103,104 Est. Cost $3.84 Unrealized
AKBA AKEBIA THERAPEUTICS INC 0.2%
Value ($000) $288 Shares 100,000 Est. Cost $3.37 Unrealized -15.2%
BCRX BIOCRYST PHARMACEUTICALS INC 0.2%
Value ($000) $287 Shares 20,000 Est. Cost $6.02 Unrealized +162.1%
LSF LAIRD SUPERFOOD INC 0.2%
Value ($000) $267 Shares 14,000 Est. Cost $37.50 Unrealized
AVEO PHARMACEUTICALS INC 0.2%
Value ($000) $247 Shares 40,000 Est. Cost $6.17 Unrealized
IVERIC BIO INC 0.2%
Value ($000) $244 Shares 15,000 Est. Cost $16.27 Unrealized
IRTC IRHYTHM TECHNOLOGIES INC 0.2%
Value ($000) $234 Shares 4,000 Est. Cost $52.99 Unrealized 0.0%
SIENTRA INC 0.2%
Value ($000) $229 Shares 40,000 Est. Cost $7.95 Unrealized
ARQT ARCUTIS BIOTHERAPEUTICS INC 0.1%
Value ($000) $215 Shares 9,000 Est. Cost $31.23 Unrealized -27.0%
IFRX INFLARX NV 0.1%
Value ($000) $181 Shares 70,000 Est. Cost $3.70 Unrealized -28.9%
YIELD10 BIOSCIENCE INC 0.1%
Value ($000) $113 Shares 18,785 Est. Cost $6.02 Unrealized
THERAPEUTICSMD INC 0.1%
Value ($000) $74 Shares 100,000 Est. Cost $1.34 Unrealized
CONCERT PHARMACEUTICALS INC 0.0%
Value ($000) $65 Shares 20,000 Est. Cost $5.00 Unrealized